The week in review

Two drugs have been causing debate this week: cannabis and, predictably, codeine A group of doctors wrote to the Medical Journal of Australia on behalf of the Royal Australasian College of Physicians (RACP), sharing their concerns that the introduction of medicinal cannabis has not followed the usual research-based safety and effectiveness processes. But Professor Iain